Cresco Labs is trading 12.47% down now at $0.64 after a DEA administrative law judge paused pending marijuana rescheduling proceedings, a sector-wide catalyst reported to have sent cannabis stocks lower. - No new company-specific announcement was identified for October 1; the latest filing located was September 24’s shareholder circular for a potential senior U.S. exchange listing. - The broader market was modestly higher, so it does not appear to explain the drop.